The dynamics associated with FLT3/ITD+ AML indicate that distinct mechanisms of resistance and MRD are operative in this disease, thus making it an ideal model to study the effects of novel therapeutic approaches. The gene discussed is FLT3; the disease is acute myeloid leukemia.